DAIAD Trademark

Trademark Overview


On Thursday, October 17, 2024, a trademark application was filed for DAIAD with the United States Patent and Trademark Office. The USPTO has given the DAIAD trademark a serial number of 98806669. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 17, 2024. This trademark is owned by StradBio, Inc.. The DAIAD trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of treatment of oncological diseases, disorders, and conditions, and clinical trials and post-market trials related to treatment of oncological diseases, disorders, and conditions; consulting services in the field of research and development of treatments, pharmaceuticals, and therapeutics for oncological diseases, disorders, and conditions; cancer treatment research and development; providing medical and scientific research information in the field of treatment of inflammatory diseases, disorders, and conditions, and clinical trials and post-market trials related to treatment of inflammatory diseases, disorders, and conditions; consulting services in the field of research and development of treatments, pharmaceuticals, and therapeutics for inflammatory diseases, disorders, and conditions; cancer treatment research and development; research in the field of bioengineering; research in the field of molecular engineering; ...
daiad

General Information


Serial Number98806669
Word MarkDAIAD
Filing DateThursday, October 17, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, October 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding medical and scientific research information in the field of treatment of oncological diseases, disorders, and conditions, and clinical trials and post-market trials related to treatment of oncological diseases, disorders, and conditions; consulting services in the field of research and development of treatments, pharmaceuticals, and therapeutics for oncological diseases, disorders, and conditions; cancer treatment research and development; providing medical and scientific research information in the field of treatment of inflammatory diseases, disorders, and conditions, and clinical trials and post-market trials related to treatment of inflammatory diseases, disorders, and conditions; consulting services in the field of research and development of treatments, pharmaceuticals, and therapeutics for inflammatory diseases, disorders, and conditions; cancer treatment research and development; research in the field of bioengineering; research in the field of molecular engineering; medical and clinical research and development for others in the field of cellular therapy; consulting services in the field of cellular therapy for scientific or research purposes, disease model systems, and drug discovery and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 17, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameStradBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20004

Trademark Events


Event DateEvent Description
Thursday, October 17, 2024NEW APPLICATION ENTERED